Recent Finacing
Recent Raise
Ocelot Bio is a clinical-stage biopharmaceutical company developing OCE-205, a peptide therapeutic targeting portal hypertension complications, advancing IND clearance to Phase 2 studies in hepatorenal syndrome and exploring ascites.
